Das Gesundheitswesen zwischen Ethik und Bezahlbarkeit (online)
Apr
06
05:00 PM - 06:15 PM
Jump directly to
Videos
Zitate
Das Territorialprinzip hat einen sehr hohen Preis. Die Ärzteschaft wie auch die Spitäler sind im Lobbying in der Politik sehr erfolgreich. Das erleben wir seit 50, 60 Jahren so. Wir müssen wohl damit leben.
Professor für Health Economics, Interpharma Stiftungsprofessur, Universität Basel
Stefan Felder
Wir sind in der Lage, ein elektronisches Patientendossier zu machen. Die Frage ist einfach, wie sieht es am Schluss aus. Können wir es, falls es nicht genügend ist, weiterentwickeln, und wie wird es gelebt?
Generalsekretärin der FMH, Rechtsanwältin und Hebamme
Ursina Pally Hofmann
Die Medizin ist eine Humanmedizin. Es braucht den Human Touch. Der Roboter wird niemals die Hand eines Sterbenden halten können. Das sind Fähigkeiten, die heute leider verloren gehen.
Direktor des European Center of Pharmaceutical Medicine, Universität Basel, Verwaltungsratspräsident der Helsana Group
Thomas D. Szucs
Fachpanel I
Trotz Pandemie – wir leben länger und gesünder als vor 10, 50 oder 100 Jahren. Der allgemeine Wohlstand und der Fortschritt in der Medizin erhöhen die Lebensqualität bis ins hohe Alter. Es liegt in der Natur des Menschen, für sich die bestmögliche Gesundheitsversorgung zu fordern. Das Schweizer Gesundheitswesen zählt denn auch bereits zu den teuersten der Welt, wobei die Krankenkassenprämien jedes Jahr auch noch zulegen. Laut dem Bundesamt für Statistik zahlten im Jahr 2016 37,2% aller Privathaushalte der Schweiz mehr für die Krankenkasse als für ihre Steuern – 2006 betrug der Anteil noch 30,1%. Wachsende Ansprüche stehen Fragen der Machbarkeit gegenüber. Wo sind die Grenzen des Wohlfahrtsstaates? Und welche Prioritäten sind zu setzen, um die Zukunftsfähigkeit der Sozialsysteme gewährleisten zu können?
Das diesjährige Wirtschaftspodium fand für einmal online statt in Form von zwei Fachpanels, die am 6. Und 8. April stattfanden. Das erste Panel stellte das Thema Gesundheitswesen ins Zentrum. Gesundheitsökonom Stefan Felder, Rechtsanwältin Ursina Pally Hofmann und Mediziner Thomas D. Szucs diskutierten über das Spannungsfeld zwischen Ethik und Bezahlbarkeit. Moderiert wurde die Diskussion von Prof. em. Peter Zweifel.
Als Anreicherung der Debatte flossen pointierte Aussagen von Politikerinnen und Politiker in die Panels ein.
Die Zuschauer des live Broadcasts hatten die Möglichkeit, im Anschluss an die Diskussion Fragen zu stellen.
Lesen Sie unsere Zusammenfassung und unseren Twitter Live-Thread.
Trotz Pandemie – wir leben länger und gesünder als vor 10, 50 oder 100 Jahren. Der allgemeine Wohlstand und der Fortschritt in der Medizin erhöhen die Lebensqualität bis ins hohe Alter. Es liegt in der Natur des Menschen, für sich die bestmögliche Gesundheitsversorgung zu fordern. Das Schweizer Gesundheitswesen zählt denn auch bereits zu den teuersten der Welt, wobei die Krankenkassenprämien jedes Jahr auch noch zulegen. Laut dem Bundesamt für Statistik zahlten im Jahr 2016 37,2% aller Privathaushalte der Schweiz mehr für die Krankenkasse als für ihre Steuern – 2006 betrug der Anteil noch 30,1%. Wachsende Ansprüche stehen Fragen der Machbarkeit gegenüber. Wo sind die Grenzen des Wohlfahrtsstaates? Und welche Prioritäten sind zu setzen, um die Zukunftsfähigkeit der Sozialsysteme gewährleisten zu können?
Das diesjährige Wirtschaftspodium fand für einmal online statt in Form von zwei Fachpanels, die am 6. Und 8. April stattfanden. Das erste Panel stellte das Thema Gesundheitswesen ins Zentrum. Gesundheitsökonom Stefan Felder, Rechtsanwältin Ursina Pally Hofmann und Mediziner Thomas D. Szucs diskutierten über das Spannungsfeld zwischen Ethik und Bezahlbarkeit. Moderiert wurde die Diskussion von Prof. em. Peter Zweifel.
Speakers
Stefan Felder has been a professor of health economics at the University of Basel since 2011, after stints at the Otto von Guericke University Magdeburg and the University of Duisburg-Essen. He is President of the Swiss Society for Health Economics and Managing Director of the European Health Economic Association. The German Society for Health Economics awarded him the Gérard Gäfgen Medal in 2019 for his special services to the subject. He has written a well-known textbook on medical decision making and is a member of the Swiss Medical Board, which regularly publishes recommendations on medical services. Stefan Felder is a sought-after reviewer and is constantly commenting on health policy issues in the media.
Ursina Pally Hofmann has been General Secretary and Head of Legal Services at FMH since 2018. The lawyer has been working in various health care functions since she started her career as a midwife; in various hospitals, a law firm, an insurance group and at FMH. She is also a member of the Joint Health Region Commission of the cantons of Basel-Stadt and Basel-Landschaft, part-time commercial judge in the Canton of Zurich and lecturer in law at the Health Department of the Zurich University of Applied Sciences.
Prof. Dr.med. Thomas D. Szucs has been Chairman of the Board of Directors of the leading Swiss health and accident insurer, the Helsana Group, since 2010. Thomas Szucs is a professor and director of the Institute for Pharmaceutical Medicine at the University of Basel, Switzerland. Since 2014 he has been consulting for personalized and genomic medicine. Previously, Thomas Szucs held various management positions. Among other things, he was head of the Department of Medical Economics at the University of Zurich; Chief Operating Officer and Chief Medical Officer of the Hirslanden Group; Head of research and founder of the Center for Pharmacoeconomics at the University of Milan; Head of the working group for clinical economics at the University of Munich; Senior Consultant at Arthur D. Little, Inc .; and head of the Department of Health Economics at F. Hoffmann-La Roche AG in Basel worldwide. Thomas Szucs has many years of experience on the supervisory boards / boards of directors of private and listed biotechnology companies and associated companies. After studying medicine and receiving his doctorate from the University of Basel, Thomas Szucs earned a master's degree in business administration from the University of St. Gallen, a master's degree in public health from Harvard University and an LL.M. in International Business Law at the University of Zurich. He is an FMH specialist for pharmaceutical medicine, prevention and healthcare. In 2010 he was appointed Honorary Professor at the Center for Health Sciences at Beijing University.
Peter Zweifel graduated with a doctorate from the University of Zurich in 1974 and then spent a year at the University of Wisconsin (Madison), where he completed his knowledge of econometrics at Prof. A.S. Goldberger and thanks to Prof. B.A. Weisbrod found interest in health economics. This interest resulted in his habilitation thesis “An economic model of doctor behavior” (Springer, 1982). After a visiting professorship at the University of the Federal Armed Forces in Munich, he was elected assistant professor in 1984 and full professor for applied microeconomics at the University of Zurich in 1990. Peter Zweifel has published over 100 articles in peer-reviewed journals and is a co-author of several textbooks. From 1996 to 2005 he served as a member of the Swiss competition authority and from 2001 to 2008 as founder and publisher of the International Journal of Health Care Finance and Economics (since 2014 International Journal of Health Management and Economics). He retired in August 2011 and has since worked as a visiting professor at various universities and at the Diplomatic Academy in Vienna with the lecture "Energy Economics".
Stefan Felder has been a professor of health economics at the University of Basel since 2011, after stints at the Otto von Guericke University Magdeburg and the University of Duisburg-Essen. He is President of the Swiss Society for Health Economics and Managing Director of the European Health Economic Association. The German Society for Health Economics awarded him the Gérard Gäfgen Medal in 2019 for his special services to the subject. He has written a well-known textbook on medical decision making and is a member of the Swiss Medical Board, which regularly publishes recommendations on medical services. Stefan Felder is a sought-after reviewer and is constantly commenting on health policy issues in the media.
Ursina Pally Hofmann has been General Secretary and Head of Legal Services at FMH since 2018. The lawyer has been working in various health care functions since she started her career as a midwife; in various hospitals, a law firm, an insurance group and at FMH. She is also a member of the Joint Health Region Commission of the cantons of Basel-Stadt and Basel-Landschaft, part-time commercial judge in the Canton of Zurich and lecturer in law at the Health Department of the Zurich University of Applied Sciences.
Prof. Dr.med. Thomas D. Szucs has been Chairman of the Board of Directors of the leading Swiss health and accident insurer, the Helsana Group, since 2010. Thomas Szucs is a professor and director of the Institute for Pharmaceutical Medicine at the University of Basel, Switzerland. Since 2014 he has been consulting for personalized and genomic medicine. Previously, Thomas Szucs held various management positions. Among other things, he was head of the Department of Medical Economics at the University of Zurich; Chief Operating Officer and Chief Medical Officer of the Hirslanden Group; Head of research and founder of the Center for Pharmacoeconomics at the University of Milan; Head of the working group for clinical economics at the University of Munich; Senior Consultant at Arthur D. Little, Inc .; and head of the Department of Health Economics at F. Hoffmann-La Roche AG in Basel worldwide. Thomas Szucs has many years of experience on the supervisory boards / boards of directors of private and listed biotechnology companies and associated companies. After studying medicine and receiving his doctorate from the University of Basel, Thomas Szucs earned a master's degree in business administration from the University of St. Gallen, a master's degree in public health from Harvard University and an LL.M. in International Business Law at the University of Zurich. He is an FMH specialist for pharmaceutical medicine, prevention and healthcare. In 2010 he was appointed Honorary Professor at the Center for Health Sciences at Beijing University.
Peter Zweifel graduated with a doctorate from the University of Zurich in 1974 and then spent a year at the University of Wisconsin (Madison), where he completed his knowledge of econometrics at Prof. A.S. Goldberger and thanks to Prof. B.A. Weisbrod found interest in health economics. This interest resulted in his habilitation thesis “An economic model of doctor behavior” (Springer, 1982). After a visiting professorship at the University of the Federal Armed Forces in Munich, he was elected assistant professor in 1984 and full professor for applied microeconomics at the University of Zurich in 1990. Peter Zweifel has published over 100 articles in peer-reviewed journals and is a co-author of several textbooks. From 1996 to 2005 he served as a member of the Swiss competition authority and from 2001 to 2008 as founder and publisher of the International Journal of Health Care Finance and Economics (since 2014 International Journal of Health Management and Economics). He retired in August 2011 and has since worked as a visiting professor at various universities and at the Diplomatic Academy in Vienna with the lecture "Energy Economics".